Net Cash Provided by (Used in) Financing Activities in USD of HAEMONETICS CORP from 2009 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Haemonetics Corp quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2009 to Q2 2025.
  • Haemonetics Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending June 28, 2025 was -$2.44M, a 101% decline year-over-year.
  • Haemonetics Corp annual Net Cash Provided by (Used in) Financing Activities for 2024 was $109M, a 185% increase from 2023.
  • Haemonetics Corp annual Net Cash Provided by (Used in) Financing Activities for 2023 was $38.2M.
  • Haemonetics Corp annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$100M, a 537% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

HAEMONETICS CORP Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$2.44M -$336M -101% Mar 30, 2025 Jun 28, 2025 10-Q 2025-08-07
Q2 2024 $334M +$334M Mar 31, 2024 Jun 29, 2024 10-Q 2025-08-07
Q2 2023 -$598K +$22.8M +97.4% Apr 2, 2023 Jul 1, 2023 10-Q 2024-08-08
Q2 2022 -$23.4M -$21.8M -1332% Apr 3, 2022 Jul 2, 2022 10-Q 2023-08-08
Q2 2021 -$1.63M -$151M -101% Apr 4, 2021 Jul 3, 2021 10-Q 2022-08-10
Q2 2020 $149M +$133M +826% Mar 29, 2020 Jun 27, 2020 10-Q 2021-08-11
Q2 2019 $16.1M -$2.57M -13.8% Mar 31, 2019 Jun 29, 2019 10-Q 2020-08-04
Q2 2018 $18.7M +$22.2M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q2 2017 -$3.55M +$1.44M +28.8% Apr 2, 2017 Jul 1, 2017 10-Q 2018-08-07
Q2 2016 -$4.99M +$24.8M +83.3% Apr 3, 2016 Jul 2, 2016 10-Q 2017-08-07
Q2 2015 -$29.8M -$961K -3.34% Mar 29, 2015 Jun 27, 2015 10-Q 2016-08-01
Q2 2014 -$28.8M -$38.3M -403% Mar 30, 2014 Jun 28, 2014 10-Q 2015-07-30
Q2 2013 $9.5M -$6.72M -41.4% Mar 31, 2013 Jun 29, 2013 10-Q 2014-07-31
Q2 2012 $16.2M +$11.8M +263% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-02
Q2 2011 $4.47M +$59.4M Apr 3, 2011 Jul 2, 2011 10-Q 2012-08-08
Q2 2010 -$54.9M Apr 4, 2010 Jul 3, 2010 10-Q 2011-08-10

HAEMONETICS CORP Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $109M +$70.7M +185% Mar 31, 2024 Mar 29, 2025 10-K 2025-05-21
2023 $38.2M +$139M Apr 2, 2023 Mar 30, 2024 10-K 2025-05-21
2022 -$100M -$84.6M -537% Apr 3, 2022 Apr 1, 2023 10-K 2025-05-21
2021 -$15.7M -$383M -104% Apr 4, 2021 Apr 2, 2022 10-K 2024-05-20
2020 $367M +$499M Mar 29, 2020 Apr 3, 2021 10-K 2023-05-22
2019 -$131M -$80.6M -159% Mar 31, 2019 Mar 28, 2020 10-K 2022-05-25
2018 -$50.6M +$70M +58% Apr 1, 2018 Mar 30, 2019 10-K 2021-05-26
2017 -$121M -$60.2M -99.7% Apr 2, 2017 Mar 31, 2018 10-K 2020-05-20
2016 -$60.4M +$2.21M +3.53% Apr 3, 2016 Apr 1, 2017 10-K 2019-05-22
2015 -$62.6M -$29.5M -88.9% Mar 29, 2015 Apr 2, 2016 10-K 2018-05-23
2014 -$33.2M -$12.5M -60.2% Mar 30, 2014 Mar 28, 2015 10-K 2017-05-24
2013 -$20.7M -$483M -104% Mar 31, 2013 Mar 29, 2014 10-K 2016-06-01
2012 $462M +$492M Apr 1, 2012 Mar 30, 2013 10-K 2015-05-22
2011 -$30.5M -$12.4M -68.5% Apr 3, 2011 Mar 31, 2012 10-K 2014-05-22
2010 -$18.1M -$4.11M -29.4% Apr 4, 2010 Apr 2, 2011 10-K 2013-05-20
2009 -$14M Mar 29, 2009 Apr 3, 2010 10-K 2012-05-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.